 This trial is conducted in the United States of America USA. This is an in-patient trial investigating stepwise dose increase in a period of up to 3-weeks followed by a 10-week out-patient maintenance period. A telephone contact visit is scheduled as a follow-up for the final clinic visit. A subjects participation in this trial would be expected to be up to 16 weeks. 